(Q46765942)

English

Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-alpha and the neutrophil/lymphocyte ratio

scientific article published on 20 October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239318

Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-alpha and the neutrophil/lymphocyte ratio (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239318

0 references

1 reference

based on heuristic

inferred from title

hyperandrogenism

1 reference

based on heuristic

inferred from title

author name string

Lourdes Ibáñez

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239318

Carme Valls

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239318

Francis de Zegher

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239318

language of work or name

0 references

publication date

20 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239318

Human Reproduction

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239318

21

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239318

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239318

451-456

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239318

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Current concepts in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Clinical assessment of body hair growth in women

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Measurement precision of body composition variables using the lunar DPX-L densitometer

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Testosterone receptor blockade restores cellular immunity in male mice after burn injury

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Genotyping Steroid 21-Hydroxylase Deficiency: Hormonal Reference Data*

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Levels of serum C-reactive protein during oral and transdermal estradiol in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Effects of oral and transdermal estradiol administration on levels of sex hormone-binding globulin in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI329

21 January 2018

Identifiers

10.1093/HUMREP/DEI329

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239318

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239318

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46765942&oldid=2130327198"